These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38145457)

  • 1. Omaveloxolone ameliorates isoproterenol-induced pathological cardiac hypertrophy in mice.
    Li X; Wu Y; Yang Y; Wu Y; Yu X; Hu W
    Free Radic Res; 2024 Jan; 58(1):57-68. PubMed ID: 38145457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omaveloxolone attenuates the sepsis-induced cardiomyopathy via activating the nuclear factor erythroid 2-related factor 2.
    Jian W; Ma H; Wang D; Yang P; Jiang M; Zhong Y; Long X; Jiang J; Gong Y
    Int Immunopharmacol; 2022 Oct; 111():109067. PubMed ID: 35908503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Nrf2/ARE Signalling Pathway to Mitigate Isoproterenol-Induced Cardiac Hypertrophy: Plausible Role of Hesperetin in Redox Homeostasis.
    Velusamy P; Mohan T; Ravi DB; Kishore Kumar SN; Srinivasan A; Chakrapani LN; Singh A; Varadharaj S; Kalaiselvi P
    Oxid Med Cell Longev; 2020; 2020():9568278. PubMed ID: 32952852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway.
    Guo Y; Li D; Cen XF; Qiu HL; Ma YL; Liu Y; Huang SH; Liu LB; Xu M; Tang QZ
    Oxid Med Cell Longev; 2022; 2022():8367997. PubMed ID: 35242278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins.
    Wang W; Li S; Wang H; Li B; Shao L; Lai Y; Horvath G; Wang Q; Yamamoto M; Janicki JS; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2014 Jul; 72():305-15. PubMed ID: 24747945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway.
    Nie P; Meng F; Zhang J; Wei X; Shen C
    Oxid Med Cell Longev; 2019; 2019():4625912. PubMed ID: 31285785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of dioscin against isoproterenol-induced cardiac hypertrophy via adjusting PKCε/ERK-mediated oxidative stress.
    Li R; Qi Y; Yuan Q; Xu L; Gao M; Xu Y; Han X; Yin L; Liu C
    Eur J Pharmacol; 2021 Sep; 907():174277. PubMed ID: 34171391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 protects against maladaptive cardiac responses to hemodynamic stress.
    Li J; Ichikawa T; Villacorta L; Janicki JS; Brower GL; Yamamoto M; Cui T
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1843-50. PubMed ID: 19592468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway.
    Zhao M; Guo H; Chen J; Fujino M; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Wang J; Huang H; Zheng S; Hei M; Li J; Huang S; Li J; Ma X; Chen Y; Zhao L; Zhuang J; Zhu P; Li XK
    Am J Physiol Cell Physiol; 2015 Apr; 308(8):C665-72. PubMed ID: 25652453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chrysophanol attenuated isoproterenol-induced cardiac hypertrophy by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
    Yuan J; Hong H; Zhang Y; Lu J; Yu Y; Bi X; Wang J; Ye J
    Cell Biol Int; 2019 Jun; 43(6):695-705. PubMed ID: 30977566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
    Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes.
    Liu BY; Li L; Liu GL; Ding W; Chang WG; Xu T; Ji XY; Zheng XX; Zhang J; Wang JX
    Acta Pharmacol Sin; 2021 May; 42(5):701-714. PubMed ID: 32796955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
    Liu C; Wu QQ; Cai ZL; Xie SY; Duan MX; Xie QW; Yuan Y; Deng W; Tang QZ
    J Cell Mol Med; 2019 Sep; 23(9):6466-6478. PubMed ID: 31293067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
    Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
    Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice.
    Shanmugam G; Challa AK; Litovsky SH; Devarajan A; Wang D; Jones DP; Darley-Usmar VM; Rajasekaran NS
    Redox Biol; 2019 Oct; 27():101212. PubMed ID: 31155513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoproterenol-induced hypertrophy of neonatal cardiac myocytes and H9c2 cell is dependent on TRPC3-regulated Ca
    Han JW; Kang C; Kim Y; Lee MG; Kim JY
    Cell Calcium; 2020 Dec; 92():102305. PubMed ID: 33069962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin ameliorated inflammation and oxidative stress in isoproterenol induced myocardial infarction through the endothelial nitric oxide synthase (eNOS)/nuclear factor erythroid 2-related factor-2 (NRF2)/heme oxygenase-1 (HO-1) signaling pathway.
    El-Shaer NO; El Gazzar WB; Allam MM; Anwer HM
    J Physiol Pharmacol; 2021 Apr; 72(2):. PubMed ID: 34642258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRK2 participation in cardiac hypertrophy induced by isoproterenol through the regulation of Nrf2 signaling and the promotion of NLRP3 inflammasome and oxidative stress.
    Liu J; Li X; Ding L; Li W; Niu X; Gao D
    Int Immunopharmacol; 2023 Apr; 117():109957. PubMed ID: 37012864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflammation.
    Chen D; Li Z; Bao P; Chen M; Zhang M; Yan F; Xu Y; Ji C; Hu X; Sanchis D; Zhang Y; Ye J
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1253-1264. PubMed ID: 30668979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.